CHRS Coherus Biosciences Inc

Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines.

$14.08  -0.20 (-1.40%)
As of 05/11/2021 09:33:44 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/06/2014
Outstanding shares:  75,752,478
Average volume:  846,646
Market cap:   $1,084,775,485
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    19249H103
ISIN:        US19249H1032
Sedol:      BRK0149
Valuation   (See tab for details)
PE ratio:   11.19
PB ratio:   8.18
PS ratio:   3.02
Return on equity:   -59.74%
Net income %:   -21.21%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy